Those who are looking into medical device manufacturing company sector this morning could do well to start tracking the RemSleep Holdings Inc (OTCMKTS:RMSL) stock. The company, which is involved in revolutionising the treatments for obstructive sleep apnea, came into sharp focus yesterday after it made an announcement with regards to key partnerships.
Trading Data
On Monday, RMSL stock moved up 7.57% to $0.0199 with more than 23.44 million shares, compared to its average volume of 16.43 million shares. The stock has moved within a range of $0.0180 – 0.0224 after opening trade at $0.0198.
Recent News
The company announced yesterday that it had managed to partner with MCAP Mediawire and Preya Co in order boost the level of communication and interactions with potential and current shareholders in RemSleep. It is something that all ambitious companies need since at the end of the day only effective communication with investors can lead to more investments.
However, at the same time, it ought to be noted that RemSleep decided to go for these partnerships since the response from the medical fraternity and the public has been quite overwhelming with regards to is DeltaWave 510k approval and release into the market. The latest announcement came as a source of significant encouragement to investors as well and the stock ended up with gains of as much as 8% for the day. The stock has gained momentum but it needs to be seen if it can maintain it today or not.
Technical Data
RMSL stock is trading above the 20-Day and 50-Day Moving averages of $0.0166 and $0.0147 respectively. Moreover, the stock is trading above the 200-Day moving average of $0.0165. The stock is up 63% in the past month.
